Search

Your search keyword '"Meier, W."' showing total 2,313 results

Search Constraints

Start Over You searched for: Author "Meier, W." Remove constraint Author: "Meier, W."
2,313 results on '"Meier, W."'

Search Results

205. Fachgespräch 5: Informations- und Computersicherheit

206. State of the climate in 2017

207. Ultra-high critical current densities, the vortex phase diagram and the effect of granularity of the stoichiometric high-Tc superconductor, CaKFe4As4

208. Wie ist die Evidenz für die Lyphonodektomie beim frühen Ovarialkarzinom?

210. EP1168 The influence of obesity on tumor recurrence in vulvar cancer patients

211. P193 p53 and p16 expression profiles identify three prognostically subgroups in vulvar cancer: a TMA based study by the AGO-CaRE-translational study group

212. Analysis of the London penetration depth in Ni-doped CaKFe4As4

214. Carboplatin/Caelyx/Bevacizumab vs. Carboplatin/Gemcitabine/Bevacizumab beim platinsensiblen Ovarialkarzinomrezidiv: Ergebnisse der prospektiv-randomisierten Phase III AGO-OVAR 2.21 Studie

217. State of the Climate in 2017

218. State of the climate in 2017

219. lion-lymphadenectomy in ovarian neoplasms.a prospective randomized ago study group led gynecologyc cancer intergroup trial

220. Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy

224. Substantial reduction of the anisotropy in the critical current densities Jc of Ni-doped CaKFe4As4 single crystals by chemical and irradiation-induced disorder.

227. State of the climate in 2016

231. Enhancement of critical current density in CaKFe4As4 single crystals through 3 MeV proton irradiation.

237. Lebensqualität unter Niraparib-Erhaltungstherapie bei Patientinnen mit rezidiviertem Ovarialkarzinom: Ergebnisse der AGO-OVAR 2.22-Studie (ENGOT-OV16/NOVA)

238. Sicherheit und Wirksamkeit von Niraparib bei älteren Patientinnen mit rezidiviertem Ovarialkarzinom: eine Subgruppenanalyse der AGO Ovar 2.22 (ENGOT-OV16/NOVA) Phase III Studie

239. Randomized controlled phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer – AGO DESKTOP III/ENGOT ov20

246. Optically Induced Correlated Phase in CaKFe4As4 Superconductor

Catalog

Books, media, physical & digital resources